AMEX:OGEN
Oragenics, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.oragenics.comipo date
Feb 25, 2004
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immunity from the novel severe acute re...Show More
Earnings
Earnings Release in 13 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus